Lupin launches generic HIV drug in US market

Lupin has launched generic Abacavir and Lamivudine tablets used for the treatment of human immunodeficiency infection in the American market.

The company had earlier received approval from the United States Food and Drug Administration (USFDA) for Abacavir and Lamivudine tablets 600 mg/300 mg, Lupin said in a statement.

Lupin’s tablets are generic versions of ViiV Healthcare Company’s Epzicom tablets in the same strength, it added.

The product is “indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection,” Lupin said.